YM178 OCAS Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YM178 OCAS Tablet, covering 2012-11-02 to 2012-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers [Phase 1]